Emerin is an integral membrane protein of the inner nuclear membrane. Mutations in emerin cause X-linked Emery-Dreifuss muscular dystrophy (EDMD), a disease characterized by skeletal muscle wasting and dilated cardiomyopathy. Current evidence suggests the muscle wasting phenotype of EDMD is caused by defective myogenic progenitor cell differentiation and impaired muscle regeneration. We obtained genome-wide expression data for both mRNA and micro-RNA (miRNA) in wildtype and emerin-null mouse myogenic progenitor cells. We report here that emerin-null myogenic progenitors exhibit differential expression of multiple signaling pathway components required for normal muscle development and regeneration. Components of the Wnt, IGF-1, TGF-β, and Notch signaling pathways are misexpressed in emerin-null myogenic progenitors at both the mRNA and protein levels. We also report significant perturbations in the expression and activation of p38/Mapk14 in emerin-null myogenic progenitors, showing that perturbed expression of Wnt, IGF-1, TGF-β, and Notch signaling components disrupts normal downstream myogenic signaling in these cells. Collectively, these data support the hypothesis that emerin is essential for proper myogenic signaling in myogenic progenitors, which is necessary for myogenic differentiation and muscle regeneration.
References
[1]
Dechat T, Adam SA, Taimen P, Shimi T, Goldman RD (2010) Nuclear Lamins. Cold Spring Harbor Perspectives in Biology. pp. 1–23.
[2]
Vlcek S (2007) ScienceDirect - Current Opinion in Cell Biology : Lamins and lamin-associated proteins in aging and disease. Current opinion in cell biology.
[3]
D’Angelo M, Hetzer M (2006) The role of the nuclear envelope in cellular organization. Cell Mol Life Sci.
[4]
Bione S, Maestrini E, Rivella S, Mancini M, Regis S, et al. (1994) Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8: 323–327.
[5]
Manilal S, Nguyen TM, Sewry CA, Morris GE (1996) The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet 5: 801–808.
[6]
Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J (1996) Emerin deficiency at the nuclear membrane in patients with Emery-Dreif uss …. Nat Genet.
[7]
Lin F, Blake DL, Callebaut I, Skerjanc IS, Holmer L, et al. (2000) MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. The Journal of biological chemistry 275: 4840–4847.
[8]
Melcon G, Kozlov S, Cutler DA, Sullivan T, Hernandez L, et al. (2006) Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum Mol Genet 15: 637–651.
[9]
Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, et al. (2006) Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 129: 996–1013.
[10]
Muchir A, Pavlidis P, Bonne G, Hayashi YK, Worman HJ (2007) Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum Mol Genet 16: 1884–1895.
[11]
Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, et al. (2007) Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. The Journal of clinical investigation 117: 1282–1293.
[12]
Muchir A, Shan J, Bonne G, Lehnart SE, Worman HJ (2009) Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Human molecular genetics 18: 241–247.
[13]
Kuang S, Rudnicki MA (2008) The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14: 82–91.
[14]
Massagué J, Cheifetz S, Endo T, Nadal-Ginard B (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proceedings of the National Academy of Sciences of the United States of America 83: 8206–8210.
[15]
Polesskaya A, Seale P, Rudnicki MA (2003) Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 113: 841–852.
[16]
Ridgeway AG (2000) Wnt Signaling Regulates the Function of MyoD and Myogenin. Journal of Biological Chemistry 275: 32398–32405.
[17]
Conboy IM, Rando TA (2002) The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Developmental Cell 3: 397–409.
[18]
Edwall D, Schalling M, Jennische E, Norstedt G (1989) Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 124: 820–825.
[19]
Jennische E, Hansson HA (1987) Regenerating skeletal muscle cells express insulin-like growth factor I. Acta physiologica Scandinavica 130: 327–332.
[20]
Levinovitz A, Jennische E, Oldfors A, Edwall D, Norstedt G (1992) Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotube formation. Molecular Endocrinology 6: 1227–1234.
[21]
Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, et al. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature genetics 27: 195–200.
[22]
Engert J, Berglund E (1996) Proliferation precedes differentiation in IGF-I-stimulated myogenesis. The Journal of Cell Biology.
[23]
Heron-Milhavet L, Mamaeva D, LeRoith D, Lamb NJ, Fernandez A (2010) Impaired muscle regeneration and myoblast differentiation in mice with a muscle-specific KO of IGF-IR. Journal of cellular physiology 225: 1–6.
[24]
Zhang L, Wang XH, Wang H, Du J, Mitch WE (2010) Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. Journal of the American Society of Nephrology : JASN 21: 419–427.
[25]
Kollias HD, McDermott JC (2008) Transforming growth factor-beta and myostatin signaling in skeletal muscle. Journal of applied physiology (Bethesda, Md : 1985) 104: 579–587.
[26]
Gardner S, Alzhanov D, Knollman P (2011) TGF-{beta} Inhibits Muscle Differentiation by Blocking Autocrine Signaling Pathways Initiated by IGF-II. Molecular ….
[27]
Schabort EJ, Merwe Mvd, Loos B, Moore FP, Niesler CU (2009) TGF-β’s delay skeletal muscle progenitor cell differentiation in an isoform-independent manner. Exp Cell Res 315: 373–384.
[28]
Kopan R, Nye JS, Weintraub H (1994) The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development (Cambridge, England) 120: 2385–2396.
[29]
Schuster-Gossler K, Cordes R, Gossler A (2007) Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proceedings of the National Academy of Sciences of the United States of America 104: 537–542.
[30]
Brack AS, Conboy IM, Conboy MJ, Shen J, Rando TA (2008) A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2: 50–59.
[31]
Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, et al. (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317: 807–810.
[32]
Pansters NAM, van der Velden JLJ, Kelders MCJM, Laeremans H, Schols AMWJ, et al. (2011) Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β. Cellular and molecular life sciences : CMLS 68: 523–535.
[33]
Le Grand F, Jones AE, Seale V, Scime A, Rudnicki MA (2009) Wnt7a Activates the Planar Cell Polarity Pathway to Drive the Symmetric Expansion of Satellite Stem Cells. Stem Cell 4: 535–547.
[34]
Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, et al. (2006) The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J 25: 3275–3285.
[35]
He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nature Publishing Group 5: 522–531.
[36]
Carthew RW, Sontheimer EJ (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642–655.
[37]
McCarthy JJ (2008) MicroRNA-206: the skeletal muscle-specific myomiR. Biochimica et biophysica acta 1779: 682–691.
[38]
Sweetman D, Goljanek K, Rathjen T, Oustanina S, Braun T, et al. (2008) Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Dev Biol 321: 491–499.
[39]
Chen J-F, Tao Y, Li J, Deng Z, Yan Z, et al. (2010) microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190: 867–879.
[40]
Dey BK, Gagan J, Dutta A (2011) miR-206 and -486 Induce Myoblast Differentiation by Downregulating Pax7. Molecular and Cellular Biology 31: 203–214.
[41]
Cardinali B, Castellani L, Fasanaro P, Basso A, Alemà S, et al. (2009) Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells. PloS one 4: e7607.
[42]
Gagan J, Dey BK, Layer R, Yan Z, Dutta A (2011) MICRORNA-378 targets the myogenic repressor myor during myoblast differentiation. Journal of Biological Chemistry. pp. 1–16.
[43]
Ge Y, Sun Y, Chen J (2011) IGF-II is regulated by microRNA-125b in skeletal myogenesis. The Journal of Cell Biology 192: 69–81.
[44]
Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, et al. (2006) The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nature Cell Biology 8: 278–284.
[45]
Sun Q, Zhang Y, Yang G, Chen X, Zhang Y, et al. (2008) Transforming growth factor-？-regulated miR-24 promotes skeletal muscle differentiation. Nucleic acids research 36: 2690–2699.
[46]
Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, et al. (2011) miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO reports 12: 136–141.
[47]
Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, et al. (2010) MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell metabolism 12: 341–351.
[48]
Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S, et al. (2011) Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PloS one 6: e18388.
[49]
Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, et al. (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 104: 17016–17021.
[50]
Frock RL, Kudlow BA, Evans AM, Jameson SA, Hauschka SD, et al. (2006) Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes & Development 20: 486–500.
[51]
Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, et al. (1991) Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci USA 88: 5096–5100.
[52]
Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, et al. (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Developmental biology 162: 486–498.
[53]
Dedeic Z, Cetera M, Cohen TV, Holaska JM (2011) Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes. Journal of Cell Science 124: 1691–1702.
[54]
Mozzetta C, Consalvi S, Saccone V, Forcales SV, Puri PL, et al. (2011) Selective control of Pax7 expression by TNF-activated p38alpha/Polycomb Repressive Complex 2 (PRC2) signaling during muscle satellite cell differentiation. Cell cycle (Georgetown, Tex) 10:
[55]
Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, et al. (2010) TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 7: 455–469.
[56]
Olson EN, Sternberg E, Hu JS, Spizz G, Wilcox C (1986) Regulation of myogenic differentiation by type beta transforming growth factor. Journal of Cell Biology 103: 1799–1805.
[57]
Carlson ME, Hsu M, Conboy IM (2008) Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454: 528–532.
[58]
Rosenthal SM, Cheng ZQ (1995) Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proceedings of the National Academy of Sciences of the United States of America 92: 10307–10311.
[59]
Olguín HC, Pisconti A (2011) Marking the tempo for myogenesis: Pax7 and the regulation of muscle stem cell fate decisions. Journal of cellular and molecular medicine.
[60]
Lovett FA, Cosgrove RA, Gonzalez I, Pell JM (2010) Essential role for p38alpha MAPK but not p38gamma MAPK in Igf2 expression and myoblast differentiation. Endocrinology 151: 4368–4380.
[61]
Muchir A, Worman HJ (2007) Emery-Dreifuss muscular dystrophy. Current neurology and neuroscience reports 7: 78–83.
